1. DOP36 Efficacy and safety of vedolizumab in patients with chronic active pouchitis refractory to anti-TNF therapy: Results of a retrospective multicenter study. (21st January 2022) Authors: Sallette, M; Bouhnik, Y; Nachury, M; Bellanger, C; Laharie, D; Amiot, A; Peyrin-Biroulet, L; Roblin, X; Altwegg, R; Buisson, A; Reenaers, C; Bouguen, G; Vuitton, L; Bourreille, A; Gilletta, C; Serrero, M; Hébuterne, X; Filippi, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP01 Withdrawal of infliximab or anti-metabolite therapy in Crohn's Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE). (21st January 2022) Authors: Louis J, E; Resche-Rigon, M; Laharie, D; Satsangi, J; Ding, N; Preiss, J; D'Haens, G; Picon, L; Bossuyt, P; Vuitton, L; Irving, P; Bouhnik, Y; Viennot, S; Lamb, C; Pollock, R; Baert, F; Nachury, M; Mathurin, F; Gilletta, C; Colombel, J F Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP24 Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn's disease. (25th January 2019) Authors: Fumery, M; Peyrin-biroulet, L; Nancey, S; Altwegg, R; Veyrard, P; Bouguen, G; Viennot, S; Poullenot, F; Filippi, J; Buisson, A; Bozon, A; Gilletta, C; Brazier, F; Pouillon, L; Flourié, B; Boivineau, L; Siproudhis, L; Laharie, D; Roblin, X; Treton, X Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P140 Immunomodulators are protective against severe COVID 19: results from a large multicentre cohort of inflammatory bowel disease patients. (21st January 2022) Authors: Vuitton, L; Bourrier, A; Uzzan, M; Nachury, M; Amiot, A; Roblin, X; Allez, M; Altwegg, R; Vidon, M; Bourreille, A; Serrero, M; Pelletier, A L; Filippi, J; Gilletta, C; Simon, M; Laharie, D; Nahon, S; Duveau, N; Biron, A; Viennot, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P404 Persistence of subcutaneous infliximab after switching from intravenous in a French national cohort of IBD patients in remission. (30th January 2023) Authors: Mathieu, N; Riviere, P; Heluwaert, F; Hébuterne, X; Chupin, A; Bouguen, G; Vuitton, L; Allez, M; Montuclard, C; Nachury, M; Nancey, S; Amélie, B; Gilletta, C; Abitbol, V; Altwegg, R; de Maissin, A; Plastaras, L; Ah Soune, P; Boureille, A; Bouhnik, Y Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study. (30th January 2023) Authors: Le Cosquer, G; Gilletta, C; Amiot, A; Rivière, P; Nachury, M; Rouillon, C; Bouhnik, Y; Abitbol, V; Nancey, S; Fumery, M; Savoye, G; Biron, A; Picon, L; Peyrin-Biroulet, L; Vidon, M; Reenaers, C; Simon, M; Caron, B; Serrero, M; Altwegg, R Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P504 Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study. (27th May 2021) Authors: Fumery, M; Filippi, J; Abitbol, V; Biron, A; Laharie, D; Serrero, M; Altwegg, R; Bouhnik, Y; Peyrinbiroulet, L; Gilletta, C; Roblin, X; Pineton de Chambrun, G; Vuitton, L; Bourrier, A; Nancey, S; Gornet, J M; Nahon, S; Bouguen, G; Viennot, S; Pariente, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P593 Efficacy, tolerance and safety of low-volume bowel preparations in inflammatory bowel diseases: Results from a French national multicentre study. (16th January 2018) Authors: Briot, C; Faure, P; Parmentier, A L; Gay, C; Trang, C; Nachury, M; Viennot, S; Altwegg, R; Bulois, P; Thomassin, L; Serrero, M; Ah Soune, P; Gilletta, C; Plastaras, L; Simon, M; Dray, X; Caillo, L; Del Tedeco, E; Abitbol, V; Zallot, C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P604 Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study. (21st January 2022) Authors: Bozon, A; Serrero, M; Caillo, L; Gilletta, C; Benezech, A; Nancey, S; Combes, R; Danan, G; Akouete, S; Pages, L; Bourgaux, J F; Boivineau, L; Meszaros, M; Altwegg, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P638 Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study. (30th January 2023) Authors: Fumery, M; Defrance, A; Roblin, X; Altwegg, R; Caron, B; Hebuterne, X; Carmen, S; Meyer, A; Nachury, M; Laharie, D; Nancey, S; Le Berre, C; Serrero, M; Geyl, S; Gilletta, C; Ah Soune, P; Duveau, N; Uzza, M; Abitbol, V; Biron, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗